Clinical Trials Browser

Phase 2 × Terminated × Ado-Trastuzumab Emtansine × Clear all

NCT04675827 2024-12-04

Decrescendo

Phase 2 Terminated

Breast Neoplasms

NCT03784599 2022-11-10

TRAEMOS

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT03894007 2021-09-23

PREDIXIIHER2

Phase 2 Terminated

Breast Neoplasms

NCT01702558 2021-01-22

TRAXHER2

Phase 2 Terminated

182 enrolled 44 charts

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms